Exploring the possibility of several commonly used drugs that may potentially alter cancer risks for type 2 diabetic patients.
Examining cardiovascular and cerebrovascular safety of several commonly used drugs.
Examining the potential benefit and harm of HMG-CoA reductase inhibitors (statins).
Investigating the national health policy impact on healthcare system.
Thyroid dysfunction and cardio-metabolic risks.
Relation between metabolic factors and infectious disease.